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S U M M A R Y
Objectives: The objectives of this study were to assess the case ascertainment and completeness of
neonatal tetanus (NT) reporting and to estimate the incidence of NT in Dadu District, Pakistan.
Methods: We conducted active surveillance and hospital record reviews for suspected NT cases. We
compared the cases of NT reported to the routine surveillance system with the cases identiﬁed through
the hospital record reviews for 1993 through 2003. The two-source capture–recapture method was used
to evaluate case ascertainment in the routine surveillance system and to estimate the incidence of cases
of NT.
Results: Active surveillance and hospital record reviews identiﬁed 134 cases in addition to 274 cases in
the routine surveillance system. The two-source capture–recapture method indicated that there would
have been 463 cases during this period (95% conﬁdence interval (CI) = 418–508), representing an
average annual incidence of 0.62 per 1000 live-births. The overall completeness of routine reporting was
59.2%. The proportions of cases reported were 68.1% for government hospitals and 53.8% for private
reporting sites.
Conclusions: Reporting of NT cases is incomplete. Active promotion of private sector participation,
community involvement, and strengthening of the government sector as a way of improving NT
reporting and surveillance is strongly suggested.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
The success of an immunization program in reducing the
morbidity and mortality from vaccine-preventable diseases can be
measured only if there is a reliable disease surveillance system.1
Neonatal tetanus (NT) is the second leading cause of death from
childhood vaccine-preventable diseases worldwide2 and one of the
most underreported diseases.3 Underreporting of NT cases is of
major public health concern to the global elimination of neonatal
tetanus. Concerns about the underreporting of NT in developing
countries have limited the impact of surveillance on disease
control strategies, yet little consideration has been given to ways of
improving the reporting system.
Completeness of reporting depends primarily on three ele-
ments.1 First, the public must have access to health services, and
second, must use them. Third, the health services must report cases
accurately and regularly to the appropriate health authorities.1
Community-based NT mortality surveys indicate that current* Corresponding author. Tel.: +1 403 329 2676; fax: +1 403 329 2668.
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2–8% of cases.1,3–6 The World Health Organization (WHO) received
reports of only 9318 cases of NT in 2004,7 compared to an
estimated 128 000 NT deaths.8
NT is a highly fatal infection of the neonatal period, usually
occurring in rural settings where there is poor access to health
facilities and most deaths occur at home, with birth and death not
being reported.9 The development of effective surveillance through
correct and accurate reporting will not only help to target and
evaluate interventions,9 but will also replace the survey method
for obtaining data on the morbidity and mortality of NT.4
Integration and expansion of acute ﬂaccid paralysis (AFP)
surveillance with measles and NT reporting,9–11 building on the
experience of polio surveillance and community-based NT
reporting,12 are some of the WHO recommendations for improving
NT surveillance.
As at December 2010, Pakistan is one of the 39 countries that
have not achieved maternal and neonatal tetanus (MNT) eradica-
tion.13 WHO recommends that surveillance systems should be
sufﬁciently sensitive to detect an annual rate of less than 1 NT case/
1000 live-births at the district level as a target for global
elimination; maternal tetanus is considered eliminated when NTses. Published by Elsevier Ltd. All rights reserved.
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clean delivery services, immunization of women with a tetanus
toxoid (TT)-containing vaccine, and effective surveillance.8,9
Dadu District (area 7866 square km, population 1.5 million;
capital Dadu Town) is in the northern part of Sindh Province.
Surveillance for NT began in the district in 1992, and
beginning in 2004, NT was actively integrated into AFP
surveillance and the district began to include suspected NT
and measles cases in the monthly reports. We perceived a need
to have baseline information prior to the change; however, our
emphasis is on the evaluation of the surveillance prior to the
change.
2. Methods
2.1. Active surveillance and retrospective record reviews
This work was carried out as part of the surveillance program
for the country and ethical review was not required. To evaluate
completeness of reporting and identify cases that were not
previously reported, active surveillance for suspected NT cases
was conducted in 2005 during reviews of hospital case records –
surveillance records and registers of seven government hospitals
and ﬁve private reporting sites (i.e., pediatricians in private
clinics). In addition, the medical records of the ﬁve private
reporting sites and of ﬁve tertiary referral hospitals in the areas
adjacent to the district were reviewed for diagnoses relating to
NT after administrative consents were obtained.
We also checked for the presence of vital events registries,
inpatient registers, outpatient registers, Health Management
Information System (HMIS), and standard case deﬁnitions for
NT, AFP, and measles14 in the seven government hospitals and
the ﬁve private reporting sites. These records included both
admission and discharge records. Each case had been diagnosed
by a physician and classiﬁed as NT according to the WHO
recommended case deﬁnition as follows: a case was deﬁned as a
neonate with normal ability to suck and cry during the ﬁrst 2
days of life and who, between 3 and 28 days of age cannot suck
normally and becomes stiff or has spasms.14 Admission and
discharge diagnoses of the cases were then reviewed and those
cases for which the diagnosis was consistent with NT as deﬁned
by WHO were placed into a separate ﬁle (hospital case records/
registers). NT case reports that were line listed in the
surveillance register during 1993–2003 were checked for
double-reporting and placed in a separate ﬁle (NT line list).
2.2. Neonatal tetanus case reporting
We compared the NT reporting from the 12 hospitals with the
ﬁve private reporting sites. In exploratory analyses, notiﬁed cases
were compared to the non-notiﬁed with respect to gender, age at
onset of symptoms, age at admission, delay in presentation,
residence, reporting sites, and ﬁnal outcome for the child (dead or
alive). All exploratory analyses were done at alpha = 0.05 for
descriptive purposes.
2.3. Case ascertainment and data sources
For this study, the primary ascertainment source was the NT
line list. The secondary ascertainment source comprised the
hospital case records/registers. The two databases were then
compared to each in order to identify cases common to both
sources. The comparison was done using deﬁned variables such as
names, age, sex, date of birth, place of residence, and admitting
hospital as identiﬁers.2.4. Estimating the incidence of NT
The average annual incidence of NT was based on the total
number of NT cases obtained by summing the number found only
in the NT list and the number found in the hospital case records/
registers. We used the two-source capture–recapture method to
estimate the incidence of NT cases and to evaluate the case
ascertainment during the period 1993–2003. The model used in
this study has been described previously for the estimation of the
incidence of AFP and for AFP case ascertainment.15 The model is
based on the comparison of cases from two sources for the
estimation of the total number of cases, N, given by the expression:
N = ab/c, where a is the total number of cases from the primary
source, b is the total number ascertained from the secondary
source, and c is the number of cases common to both sources.15
An estimate was made for the 11-year period. Data were
entered into Excel spreadsheet and analyzed with SPSS version
12.0 for Windows (SPSS Inc., Chicago, IL, USA).
3. Results
A total of 408 NT cases were identiﬁed, comprising 274 reported
cases (NT line list) and 134 cases that were found by active
surveillance. The NT line list did not capture the 134 cases that
should have been reported by the physicians in hospitals and at
private reporting sites. Based on the 274 reported cases, this was
equivalent to an average annual incidence of 0.37 per 1000 live-
births. Active surveillance identiﬁed an additional 134 NT (32.8%)
that had not been reported. Thus the average annual incidence in
routine surveillance based on a total of 408 cases was 0.55 per 1000
live-births.
The primary and secondary sources identiﬁed 274 and 328
cases, respectively, and 194 cases that were common to both. The
328 NT cases included 194 cases detected in both the NT line list
and the hospital case records/registers, 32 cases found only in the
hospital registers, and 102 cases ascertained only by the hospital
case records that met the case deﬁnition after review. Forty-eight
cases in the NT line list could not be ascertained by the secondary
source. The estimated crude total number of expected NT reports
was 463 (95% CI = 418–508) (Table 1). The average annual
incidence of NT was estimated to be 0.62 per 1000 live-births
(capture–recapture method).
Case ascertainment based on routine surveillance was estimat-
ed to be 59.2% (274/463) complete. Based on the estimated crude
total number of expected NT reports of 348 (95% CI = 298–398) for
males and 115 (95% CI = 57–173) for females, the overall
completeness of routine reporting was 60.6% (211/348) for males
and 54.8% (63/115) for females (capture–recapture method).
Figure 1 shows the trend in estimated completeness. The trends
in reporting completeness show that after an initial increase to 81%
in 1994, completeness ﬂuctuated between 63% and 74% during
1995–1999 and then decreased from 35% in 2000 to 19% in 2002,
concurrent with an increase in the number of unreported cases.
Further analysis showed that of the 134 cases that were
identiﬁed through active surveillance, 122 (91.0%) were found in
government hospitals and 12 (9.0%) at private reporting sites.
Records of 105 cases (78.4%) that were not previously reported
were found in registers in government hospitals, emphasizing the
signiﬁcance of actively searching for suspected NT cases during
routine reviews (Table 2). Routine reviews of registers in the seven
hospitals and in the ﬁve private reporting sites showed that none of
the hospitals and private reporting sites had birth registers, and
only two out ﬁve private reporting sites (40%) had standard case
deﬁnitions of AFP, measles, and neonatal tetanus (Table 3). The
government hospitals sent 260 (94.9%) routine NT reports, while
the private reporting sites accounted for 14 (5.1%) reports. Overall,
Table 2
Distribution of neonatal tetanus cases identiﬁed through active surveillance, 1993–
2003 (n = 134)
Source No. %
Outpatient registers 15 11.2
Inpatient registers 77 57.5
Surveillance registers 13 9.7
Private reporting sites 12 8.9
Immediate notiﬁcation form 13 9.7
Case records 4 3.0
Total 134 100
Table 1
Crude and stratiﬁed analysis of neonatal tetanus ascertainment: cases ascertained and estimated total cases, 1993–2003
Total from
active search
Total from NT line
list (primary source) (a)






number of cases N
95% CI for N
Crude analysis 274 328 194 463 418–508
Stratiﬁed by year:
1993 12 16 27 15 29 13–46
1994 10 43 51 41 53 39–66
1995 14 31 41 27 47 33–61
1996 7 35 27 20 47 33–61
1997 12 31 33 21 49 35–63
1998 8 34 28 20 48 34–62
1999 8 30 29 21 41 26–41
2000 18 17 28 10 48 34–62
2001 20 15 28 8 53 39–66
2002 21 12 26 5 62 50–74
2003 4 10 10 6 17 –
Total cases, 1993–2003 134 274 328 194 494 450–538
Figure 1. Estimated completeness of case ascertainment for neonatal tetanus, Dadu
District, Pakistan, 1993–2003.
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government hospitals and 53.8% (14/26) for private reporting sites
(Table 4).
Out of a total of 408 NT cases, the percentages of male and
female cases routinely notiﬁed were 69.9% (211/302) and 59.4%Table 3
Routine reviews of registers at government hospitals and private reporting sites
Variable Government
hospitals
(n = 7), n (%)
Private
reporting sites
(n = 5), n (%)
Had an outpatient register 7 (100) 0
Had an inpatient register 6 (86) 5 (100)
Had a birth register 0 0
Had standard case deﬁnitions
for AFP, measles, and
neonatal tetanus
7 (100) 2 (40)
Had zero reporting 7 (100) 5 (100)
Submitted all four previously
required reports
7 (100) 5 (100)
Had a functioning HMIS 7 (100) NA
AFP, acute ﬂaccid paralysis; HMIS, health management information system; NA, not
applicable.(63/106), respectively (p = 0.049). Cases reported to the routine
surveillance did not differ signiﬁcantly from those identiﬁed by
active surveillance and hospital record and register reviews with
regard to age at onset of symptoms (i.e., incubation period), age at
admission, delay in presentation, residence (rural or urban),
reporting site (government or private), and ﬁnal outcome for the
child (dead or alive) (Table 4).
4. Discussion
Both the average annual incidence in routine surveillance and
the average annual incidence by capture–recapture method of 0.55
and 0.62 per 1000 live-births, respectively, are below the WHO
target of 1 case per 1000 live-births, the global elimination goal.
The surveillance data indicated that we may be missing cases and
this was the reason for the active surveillance for suspected cases.
Completeness of reporting for NT depends on access to health
services, health seeking behavior, utilization of health services,
conscientious notiﬁcation,1 and a sensitive surveillance system.7,9
In our study, the overall completeness of routine reporting under
passive surveillance was 59%. Reporting may also have changed
over time since the onset of active surveillance in 2005. An
assessment of the completeness of ascertainment of disease
reporting systems for NT is difﬁcult for several reasons. First, most
NT deaths occur at home, with birth and death not reported.9
Second, we do not know the proportion of NT cases for whom
health care is sought, and third, despite underreporting, the true
number of NT cases in the community is not known. Although the
incidence rates in this study are below the global elimination goal,
the surveillance data suggest substantial underreporting, as the
number of cases and NT incidence rates vary from one geographical
area of the district to another (data not shown).
The ﬁnding of 134 (33%) cases that were not routinely reported
suggests that healthcare professionals, having correctly made the
diagnosis of NT, did not report the cases, particularly in areas
where most of the NT cases resided. Thus underreporting of NT
cases may be due to the failure of healthcare professionals to report
diagnosed NT cases. Although we did not explore the reasons for
failure to report, it has been hypothesized that workers may still
fear the consequences of reporting.16 However, the ﬁnding relating
to the limited availability and use of registers and case deﬁnitions
in private reporting sites suggests that the availability and
widespread use of birth attendant logs, vital events registries,
and standard case deﬁnitions in hospitals and private reporting
sites may impact on NT reporting and surveillance.
Our results suggest an active promotion of private sector
participation and strengthening of the government sector as a way
Table 4
Comparison of the characteristics of reported and unreported neonatal tetanus cases, Dadu District, Pakistan
Variable Reported cases Unreported cases p-Value
Number, N 274 134
Reporting sources/location of cases,a n (%)
Hospitals 244 (89) 83 (62)
Private pediatrician clinics 14 (5) 12 (9)
Tertiary referral hospitals outside district 16 (6) 39 (29)
Gender, n (%) 0.049
Male 211 (77) 91 (68)
Female 63 (23) 43 (32)
Male:female ratio 3.3:1 2.1:1
Residence, n (%) 0.323b
Rural 239 (87) 116 (87)
Urban 35 (13) 12 (9)
Unknown – 6 (4)
Rural:urban ratio 6.8:1 9.6:1
Age at onset of symptoms (days), mean  SD 6.3  2.7 6.6  2.8 0.609
Age on admission (days), mean  SD 8.1  3.1 8.3  4.1 0.659
Delay in presentation (days), mean  SD 1.7  1.5 2.0  2.1 0.268
Final outcome of child’s health, n (%) 0.308c
Discharged alive 97 (35) 56 (42)
Dead 89 (33) 34 (25)
Discharged against medical advice 41 (15) 12 (9)
Unknown 47 (17) 32 (24)
Case fatality ratio, % 47.8 37.8
Reporting sites, n (%)
Government 260 (95) 122 (91) 0.135
Private 14 (5) 12 (9)
SD, standard deviation.
a Location of cases for unreported cases.
b Excluding the six unreported cases for whom residence was unknown.
c Excluding the 79 cases for whom the outcome was unknown.
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previously suggested.16 Such promotion should include adequate
supply of resources for reporting, provision of regular feedback
from the health authority to health workers, and training and
retraining, not only of all health personnel involved in maternal
and child health activities, but also community informants,
traditional birth attendants, and primary healthcare workers
(known in Pakistan as lady health workers) and their sensitization
to enquire about and report cases of neonatal death and NT. One
study on community involvement in surveillance in Cambodia in
which lay people were trained as village health volunteers to
detect suspected outbreaks, reported a sensitivity of reporting of
communicable disease ranging from 65% for malaria to 93% for
measles.17
We believe that the decline in the reporting rate in 2000–2002
may be attributed to the implementation of TT supplementary
immunization activities (SIAs) in Dadu District during 2001–
2003, for two reasons. First, the decline occurred before and
during the TT SIAs campaign. Second, the decline correlated with a
decrease in the number of reported cases and with an increase in
the number of unreported cases from eight in 1999 to 18 in 2000
and 21 in 2002. A TT SIAs campaign is a time to increase
community awareness of NT and to increase demand for TT
vaccine among women of childbearing age. Our study shows that
the highest numbers of unreported cases were detected during
this time, suggesting that the TT SIAs campaign may not have led
to increased community awareness and to increased reporting
behavior. It appears that the degree of underreporting may be a
reﬂection of both the inadequate knowledge of reporting
requirements by health professionals and low community
awareness.
Accurate and prompt reporting and active surveillance for
suspected cases in high-risk districts, especially in ‘silent’ areas
where routine surveillance is unreliable or not taking place at all,
are essential surveillance activities.18 We did not identify any
factors associated with reporting completeness, as reportingcompleteness appears to be most strongly related to the disease
or condition being reported and geographical location appears to
be less important in determining disease-reporting complete-
ness.19 The differential reporting of male cases in our study might
reﬂect gender bias in care seeking and to cultural practices giving
preference to the survival of male children in this area. More
complete reporting of cases including female cases is needed, and
surveillance data should be corrected for gender bias.3
Similar studies have examined the incidence of NT20 and the
sensitivity of the surveillance system and reporting. Singh et al.
(1997) estimated a sensitivity of 8–13% for the NT surveillance
system in India by comparing the number of cases routinely
reported with that estimated by survey.6 Although community-
based NT mortality surveys have shown the magnitude and
distribution of NT in the population,5,21,22 these surveys are not
cost-effective for the routine monitoring of NT mortality.5 Our
study is different in that it compares the observed incidence with
that of the estimate from the two-source capture–recapture
method.
Our study is beset with several limitations, most importantly
the assumptions that are inherent in the capture–recapture
methods for the estimation of incidence. The assumptions
underlying these methods are that the data sources are indepen-
dent, that the probability of being present or ‘captured’ in one data
source is unrelated to the probability of being present in the other
data sources, and that cases are correctly identiﬁed, i.e., diagnosed
and linked.19,23 Therefore, data validation is an important aspect of
accurately applying capture–recapture methods.19
The routine surveillance data, which relies on reporting by
pediatricians and physicians, is the responsibility of the district
health ofﬁce, while the hospital discharge data are the responsi-
bility of the hospital information staff. The consistency of the
estimates across the crude and stratiﬁed data further lends
credence to the independence of the two sources. However our
study was not able to ascertain whether cases had the same
probability of being captured by either of the two sources.
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population with cross-notiﬁcations from the ﬁve tertiary referral
hospitals across the district’s boundary. We are conﬁdent in the
validation of the cases common to both sources given the high
discriminatory combination of the identifying variables. However,
given the possibility that the clinical presentations of the causes of
early neonatal death may be indistinguishable from NT, and due to
delays in diagnosis, we cannot completely exclude the probability
that clinicians may have missed some NT cases that were not
notiﬁed. Surveillance ﬁgures miss those NT deaths that occur at
home with birth and death not being reported and those who do not
seek medical care at the hospital.9,24 In spite of the potential for both
underreporting and misclassiﬁcation of cases, our risk estimates are
relatively insensitive to either of these biases.
Another limitation of our study was the biased estimates of
reporting. Bias can occur when the data collection/reporting
system excludes part of the population.7 This present study did not
report any neonatal deaths or NT cases from the community, and a
signiﬁcant proportion of NT reporting was missing from the private
sector, which was not reported to the routine surveillance system.
Since 1999, the completeness of NT surveillance (i.e., the number
and proportions of health facilities reporting at least one case of NT)
in the district has increased substantially (>80%) due to ongoing
improvements in the HMIS. However, more efﬁcient and accurate
NT surveillance might result from the linkage of the data from the
HMIS and the Expanded Programme on Immunization (EPI)
reporting systems into the active surveillance system. The data
may then be subjected to a ‘capture–recapture’ analysis to calculate
a new estimate of the overall incidence of NT cases.25 Evaluation of
the impact of the integration and expansion of AFP surveillance on
NT and on the community-based reporting of NT is urgently needed.
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